Lex

Why split Reckitt Benckiser?

Reckitt Benckiser is demerging its pharmaceuticals division with a planned listing of the renamed Indivior by Christmas. Lex’s Robert Armstrong and Oliver Ralph discuss why RB has split when there appears to be little value to unlock.